Latest Breaking News On - Goodridge foundation - Page 1 : vimarsana.com

 E-Mail Research led by scientists at Children s Cancer Institute and published this week in the international journal, Clinical Cancer Research, has found a combination of therapies that appears to be highly effective against high-risk neuroblastoma and other forms of aggressive childhood cancer. Up to half of all cases of neuroblastoma newly diagnosed in children are high-risk , meaning the cancer grows aggressively and is difficult to treat. Despite receiving intensive treatment, most children with high-risk disease die within five years of diagnosis, while those who survive are often left with serious long-term health effects. Professor Michelle Haber AM, a senior author on the paper and co-head of the Molecular Targets and Cancer Therapeutics theme at Children s Cancer Institute, said children diagnosed with high-risk neuroblastoma have less than a 50-50 chance of survival. That is a devastating prognosis. We are absolutely determined to find better ways to treat this

New south walesLin xiaoTania ewingNational healthKids cancer allianceCancer instituteTenix foundationCancer councilStanford brown inc sydneyExperimental therapeutics groupGoodridge foundationChildren cancer instituteResearch councilClinical cancer researchAnthony rothe memorialMolecular targets